A Wednesday night earnings report left big questions about how the spending reductions would affect the company.

Genomics company 10x and Harvard University have agreed to resolve a patent lawsuit against 10x's rival Vizgen four days into ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to Targeted Genomics’ GlutenID test, designed to ...

Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), ...

Arima Genomics expands executive team with three strategic hires to advance clinical applications of 3D genomics.

A major new investment into genomics research highlights the importance of genomics to New Zealand's future wellbeing and ...

Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...

Analysts at Leerink Partnrs decreased their Q1 2025 earnings estimates for shares of 10x Genomics in a research note issued to investors on Thursday, February 13th. Leerink Partnrs analyst P. Souda ...

Pharmacogenomics – an individual's genetic response to medications – is an increasingly important strand of personalised healthcare but little is known about the public's views on it.

SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO)(the “Company”) today announced that it will effect a reverse stock split of its issued and outstanding common ...

实验室分析仪器板块的领军企业Singular Genomics Systems, Inc. (NASDAQ: OMIC )，目前市值5061万美元，今日宣布其股东已投票批准一项合并协议，该协议将使公司成为Singular Genomics Parent, LLC的全资子公司。根据InvestingPro数据显示，该公司的现金持有量超过债务，但其现金储备正在快速消耗。

BGI Genomics' Indonesian joint venture NGI signed a partnership agreement for research collaboration with  Indonesian ...